M vs MRNA · P/E 6.4, rev $22.62B vs rev $145.0M
Macy’s Inc (M) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Macy’s Inc (M) is a department stores company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported M revenue for 2026-01-31 was $22.62B. Net income was $642.0M. Revenue was down 1.7% from 2025-02-01 to 2026-01-31. M currently screens at market cap $3.46B and trailing P/E 6.4.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
M currently screens at market cap $3.46B and trailing P/E 6.4. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the M and MRNA stock pages for the full models.
Not investment advice.